Any oxygen concentrator has several costs over its lifetime. The cost that is most familiar and easily understood is the upfront or initial cost of the device. However, if we look at the total cost of operating an oxygen concentrator over its five year lifetime, there are two other
significant costs that we need to…

Drive DeVilbiss and Sanrai International are pleased to announce the successful installation of the PulmO2 10L Concentrators in Burundi. This installation was supported by DAK International Network (formerly DAK Foundation), Gould Family Foundation, and Lifenet International. These units are some of the very first PulmO2 devices to be shipped!

While the COVID-19 pandemic highlighted the horrors that can occur with a lack of medical oxygen, there was no independent analysis on access to oxygen. On 17 February 2025, the Lancet Global Health Commission on Medical Oxygen Security…

Institution of Engineering and Technology Abstract Drive DeVilbiss Healthcare and Sanrai International were selected to present at the Appropriate Healthcare Technologies 2024 conference by the Institution of Engineering and Technology…

Drive DeVilbiss and Sanrai presenting the PulmO2 to the Every Breath Counts Coalition

On 13 June 2024, Sanrai International and Drive DeVilbiss Healthcare presented the PulmO2 to the UK Government’s Foreign, Commonwealth, and Development Office (FCDO) with the support of the Oxygen Co-Lab, a non-profit focused on the use of and innovation in oxygen delivery systems.

WHO Member States Meeting Statement National Oxygen Scale-Up Framework-Meeting: Road to Oxygen Access Statement In 2023, the World Health Assembly adopted the landmark…

Drive DeVilbiss Healthcare, a world leading manufacturer of oxygen solutions and Sanrai International, an expert in underserved markets, held the global unveiling of the new PulmO2 10 L Oxygen Concentrator.

Amidst the chaos of the Covid-19 pandemic, a crucial issue came to light: oxygen concentrators built for well-resourced healthcare systems were being repurposed in vastly under-resourced environments worldwide. In such conditions, these machines struggled to withstand heat, humidity, and power outages, and were…

The Oxygen CoLab, funded by UK International Development, has spent the last three years working with partners from around the world to accelerate global access to oxygen in low-resource-settings.

The Oxygen CoLab exists to drive the development, uptake, and scale of fit-for-purpose oxygen concentrators in low resource settings, and we’re pleased to announce two projects we’ve funded to help get us towards this goal: Drive DeVilbiss and Kröber Medizintechnik.